Recursion Pharmaceuticals, Inc. (RXRX) vs Vericel Corporation (VCEL)

Recursion Pharmaceuticals, Inc. and Vericel Corporation are both Biotechnology companies. Recursion Pharmaceuticals, Inc. and Vericel Corporation are of similar size ($2.1B and $2.0B). Recursion Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Vericel Corporation trades at 82.6×. Vericel Corporation grew revenue faster over the last twelve months: 23.0% against −15.1%. Vericel Corporation has the higher net margin (7.91% vs −945.9%) and the higher return on invested capital (5.49% vs −92.2%). Across the 19 metrics below, Vericel Corporation leads on 17 and Recursion Pharmaceuticals, Inc. on 2.